Qternmet XR is a combination diabetes medication containing dapagliflozin, metformin, and saxagliptin. The medication has been discontinued and is no longer available in the U.S.
| Common Brands | Qternmet XR |
|---|---|
| Drug Class | SGLT2 / DPP-4 Inhibitor / Biguanide |
| Controlled Substance Classification | Not a controlled medication |
| Generic Status | No lower-cost generic available |
| Availability | Prescription only |
Prescription savings
Stop paying too much for your prescriptions. Compare prices, get pharmacy coupons, and save up to 80%.
Find expert answers to your health questions so you can make the best decisions for yourself and your family.Health conditions
Medications & treatment
Access & affordability
Our monthly healthcare membership can help you save thousands on your prescription costs.Resources
Qternmet XR is a combination medication made up of three medications that lower blood sugar. Dapagliflozin is a SGLT2 inhibitor that blocks a receptor on your kidneys and prevents the reaborption of sugar back into your body. Meformin is a biguanide that lowers the amount of sugar your body makes and absorbs from food, and improves your body's response to insulin. Saxagliptin is a DPP-4 inhibitor that blocks an enzyme to raise the amount of insulin your body makes and raise levels of other helpful gut hormones.
No, there aren't any brand or generic versions of Qternmet XR currently available. However, the individual medications are still available as separate tablets, it's just not available as a combination.
It's not clear why Qternmet XR was discontinued by the manufacturer. It's possible that the medication wasn't popular enough given the cost.
